Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1Phase 1 1

Status

Completed 3Recruiting 2Terminated 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 6Gastrointestinal 2

Conditions

Breast Neoplasms 478Carcinoma, Non-Small-Cell Lung 436Prostatic Neoplasms 277Lung Neoplasms 169Stomach Neoplasms 138Neoplasms 112Squamous Cell Carcinoma of Head and Neck 108Head and Neck Neoplasms 96Neoplasm Metastasis 92Esophageal Neoplasms 70Ovarian Neoplasms 56Pancreatic Neoplasms 41Sarcoma 39Urinary Bladder Neoplasms 38Nasopharyngeal Carcinoma 32Carcinoma, Squamous Cell 30Triple Negative Breast Neoplasms 28Carcinoma, Ovarian Epithelial 28Adenocarcinoma of Lung 27Adenocarcinoma 27Esophageal Squamous Cell Carcinoma 25Parkinson Disease 4, Autosomal Dominant Lewy Body 23Carcinoma, Transitional Cell 23Adenocarcinoma Of Esophagus 23Breast Neoplasms, Male 22Recurrence 21Unspecified Adult Solid Tumor, Protocol Specific 20Inflammatory Breast Neoplasms 20Fallopian Tube Neoplasms 20Melanoma 18

Interventions

Paclitaxel 24Hyperthermic Intraperitoneal Chemotherapy 24Cisplatin 22Oxaliplatin 17Carboplatin 17Fluorouracil 13Cytoreduction Surgical Procedures 13Bevacizumab 10Mitomycin 9Leucovorin 8Doxorubicin 8Docetaxel 6Gemcitabine 5130-nm albumin-bound paclitaxel 5Surgical Procedures, Operative 4Blood Specimen Collection 4Albumin-Bound Paclitaxel 4sodium thiosulfate 3liposomal doxorubicin 3catumaxomab 3Taxes 3Neoadjuvant Therapy 3Drug Therapy 3tremelimumab 2relacorilant 2pembrolizumab 2olaparib 2nintedanib 2epothilone B 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Peritoneal Neoplasms × Docetaxel × Clear all
NCT03740165 2026-05-04

KEYLYNK-001

Merck Sharp & Dohme LLC

Phase 3 Completed
1,367 enrolled 29 charts
Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT04583488 2024-08-09

Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis

Johns Hopkins University

Phase 1 Terminated
2 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT04840264 2024-03-18

Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting
79 enrolled
Gynecologic

Peritoneal Neoplasms

NCT04595929 2020-11-25

GASPACCO

St. Petersburg State Pavlov Medical University

Phase NA Recruiting
304 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT01504256 2018-01-23

CatuNeo

AIO-Studien-gGmbH

Phase 2 Completed
42 enrolled
Gynecologic

Adenocarcinoma, Peritoneal Neoplasms

NCT00183794 2014-05-22

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

University of Southern California

Phase 2 Completed
20 enrolled 8 charts
Gynecologic

Ovarian Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡